Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial – AstraZeneca September 22, 2023
Todd Howard on Benefit of Starfield Xbox Exclusivity: ‘When You Think of Zelda You Think of Switch’ – IGN September 6, 2023
Opdivo (nivolumab) in Combination with Cisplatin-Based Chemotherapy Shows Overall Survival and Progression-Free Survival Benefit for Cisplatin-Eligible Patients with Unresectable or Metastatic Urothelial Carcinoma in the Phase 3 CheckMate -901 Trial – Bristol-Myers Squibb July 11, 2023
Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroups – Novartis June 2, 2023
Will Bajrang Dal Ban Promise Hurt Or Benefit Cong? Rajdeep Sardesai & Shiv Aroor Share Their Views – India Today May 8, 2023
Pause in US development of AI would ‘simply benefit China,’ ex-Google boss Eric Schmidt warns – New York Post April 7, 2023
Medical experts divided on whether 2nd FDA-approved Alzheimer’s drug provides a benefit January 23, 2023January 23, 2023
In clinical trials for cancer, patients often overestimate the benefit January 17, 2023January 17, 2023